Τόμος 27 (2009) – Τεύχος 2 – Άρθρο 5 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση – Volume 27 (2009) – Issue 2 – Article 5 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition

Γεωργία Βεσκούκη¹, Ιωάννης Αγαπίδης²

¹Τμήμα Επισκεπτών Επισκεπτριών Υγείας, Σχολή Επαγγελμάτων Υγείας και Πρόνοιας, Τεχνολογικό Εκπαιδευτικό Ίδρυμα Αθήνας, Αθήνα, Ελλάς, ²Επισκέπτης Υγείας

Giorgia Veskouki¹, John Agapidis²

¹Department of Health Visiting, Faculty of Health and Caring Professions, Technological Educational Institution of Athens, Hellas; ²Health Visitor, Athens, Hellas

2. Τούντας Γ.: Κοινωνία και Υγεία. Εκδ. Οδυσσέας, Αθήνα, 2000

3. Βελονάκης Ε.Γ.: Αγωγή Υγείας. Βασικές Αρχές. Ιατρική 45(5): 85-95 (2000)

4. Κυριόπουλος Γ., Φιλαλήθης Τ.: Η Πρωτοβάθμια Φροντίδα Υγείας στην Ελλάδα. Εκδ. Θεμέλιο, σελ. 25-79, Αθήνα, 2006

5. WHO: Declaration of Alma-Ata, Conference on Primary Health Care, Alma-Ata, USSR, 1978

6. WHO: The Ottawa Charter for Health Promotion, World Health Organization, Geneva, 1986

7. World Health Organization, Fourth International Conference on Health Promotion (4ICHP): New Partners for a New Era-Leading Health Promotion into the 21st Century. Jakarta, Indonesia, 1997

8. World Health Organization: Health 21, Health for All in the 21st Century, WHO Regional Office for Europe 1999

9. Μαρμάρας Β., Λαμπροπούλου-Μαρμάρα Μ.: Βιολογία κυττάρου – Μοριακή προσέγγιση. Εκδ. Typorama, σελ. 36-46, Πάτρα, 2000

10. Κοντογιάννη Ε., Νικολαϊδης Π.: Ιατρική Γενετική. Εκδ. Πασχαλινός, Αθήνα, 2000

11. Phillips K.A., Van Bebber S.L.: A systematic review of cost-effectiveness analyses of pharmacogenomic interventions. Pharmacogenomics 5: 1139-1149 (2004)

12. Morgan J.: Pharmacogenetics/genomics and personalized medicine. Human Molecular Genetics 14: 207-212 (2005)

13. El-Ibiary S.Y., Cheng C., Alldredge B.: Potential roles for pharmacists in pharmacogenetics, Journal American Pharmacists Association 48: 21-32 (2008)

14. Singh A., Emery J.: Pharmacogenomics: The potential guided prescribing. Australian Family Physician 36: 820-824 (2008)

15. Relling M.V., Giacomini K.M.: Pharmacogenetics. In: Goodman and Gilman’s The Pharmacological Basis of Therapeutics (Brundon L.L., Lazo J.S., Parker K.L., eds). 11th Edition. Pp. 93-115, McGRAW-Hill, New York, 2006

16. Phillips K.A., Veenstra D.L., Oren E., et al.: Potential role of pharmacogenomics in reducing adverse drug reactions: a systemic review. JAMA 286: 2270-2279 (2001)

17. The International SNP Map Working Group: A map of human genome sequence variation containing 1,4 million single nucleotide polymorphisms. Nature 2001

18. Timby N., Sjögren H., Björnstig U., Erikson A.: Crash responsibility versus drug and alcohol use among fatally injured and hospitalized motor vehicle drivers in Sweden, Alcohol Clin. Exp. Res. 22: 1838-1841 (1998)

19. Brockmoller J., Tzvetkov M.V.: Pharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment. Eur. J. Clin. Pharmacol. 64: 133-157 (2008)

20. Marsh S.: Pharmacogenomics. Ann. Oncol. 18(Suppl. 9): 24-28 (2007)

21. Swan J.J., Hulzinga T.W., Gelderblom H., dr Vries E.G.E., Assendelft W.J.J., Kirchheiner J., Guchelaar H.-J.: Translating Pharmacogenomics: Challenges on the road to the clinic. PLoS Medicine 4: 1317-1324 (2007)

22. Reitman M.L., Schadt E.E.: Pharmacogenetics of Metformin Response: a step in the path medicine. J. Clin. Invest. 117: 1226-1229 (2007)

23. Phillips K.A., Van Bebber S.L.: A systematic review of cost-effectiveness analyses of pharmacogenomic interventions. Pharmacogenomics 5: 1139-1149 (2004)

24. Buchard E.G., Ziv E., Coyle N., et al.: The importance of race and ethnic background in biomedical research and clinical practice. N. Engl. J. Med. 348: 1170-1175 (2003)